XTL Biopharmaceuticals Ltd (XTLB) stock
Close on Nov 12, 2026Market cap $15.52MP/E –Yield –
XTL Biopharmaceuticals statistics
45 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Dec 31, 2025
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
Share statisticsIndustry
- Shares Change (YoY)
- 33.2%
- 10.9%
- Float
- 946M
- 49M
- Shares Held by Insiders
- 0.00%
- 12.1%
- Shares Held by Institutions
- 0.00%
- 56.4%
Short sellingIndustry
- Short Interest
- 4,271
- –
- Short Interest Change
- 2.23%
- -0.76%
- Days to Cover
- 1.05
- 5.13
Stock price statisticsIndustry
- 52-Week High
- $5.64
- –
- 52-Week Low
- $1.52
- –
- 20-Day Moving Average
- $1.78
- –
- 50-Day Moving Average
- $2.07
- –
- 200-Day Moving Average
- $2.61
- –
- Average True Range (14)
- $0.19
- –
- Price Change (1 Week)
- -4.09%
- 1.51%
- Price Change (1 Month)
- -12.8%
- -2.37%
- Price Change (3 Months)
- -41.1%
- -21.1%
- Price Change (6 Months)
- -39.3%
- -22.8%
- Price Change (YTD)
- -29.3%
- -22.6%
- Price Change (1 Year)
- -58.6%
- -21.0%
- Price Change (3 Years)
- -55.4%
- -24.8%
- Price Change (5 Years)
- -88.6%
- -76.9%
- Price Change (10 Years)
- -89.7%
- -63.2%
- Average Volume (10 Days)
- 8,862
- –
- Average Volume (20 Days)
- 6,615
- –
- Average Volume (90 Days)
- 8,212
- –
- Relative Volume
- 0.20
- 0.80
- Relative Strength Index (14)
- 40.6
- 44.7
- Volatility (1 Year)
- 119.4%
- 80.2%
- Beta (5 Years)
- 0.98
- 1.07
Financial positionIndustry
- Interest Coverage
- -6.35
- -6.35
EfficiencyIndustry
- Employee Count
- 3
- 75
- WACC
- 9.80%
- 10.0%
Income statement (TTM)Industry
- Pretax Income
- -$759.00K
- -$13.23M
Balance sheetIndustry
- Net Cash (Debt)
- $76.00K
- $16.98M
- Net Cash Per Share
- $0.00
- $0.72
Cash flow (TTM)Industry
Taxes and interestIndustry
- Interest Expense
- $266.00K
- $2.97M
Scores and fair valueIndustry
- Altman Z-Score
- -1408.28
- 0.26
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | XTLB | S&P 500 | Difference | XTLB per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -14.6% | -2.7% | −11.9 pts | ||
| 3 months | -39.0% | -1.7% | −37.3 pts | ||
| Year to date | -29.3% | +11.9% | −41.2 pts | ||
| 1 year | -57.7% | +12.0% | −69.7 pts | ||
| 3 years | -49.4% | +78.2% | −127.6 pts | -20.3% | +21.2% |
| 5 years | -88.6% | +73.2% | −161.8 pts | -35.2% | +11.6% |
| 10 years | -89.8% | +309.6% | −399.4 pts | -20.4% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
0M XTLB shares were sold short on Oct 30, 2026, up 2.2% from the previous report. At recent volumes it would take 1.1 days to buy them back. Over the last 20 sessions, 28.8% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 4,271 | +2.2% | 4,082 | 1.1 |
| Oct 15, 2026 | 4,178 | -30.9% | 10,892 | 1.0 |
| Sep 30, 2026 | 6,050 | -15.6% | 4,749 | 1.3 |
| Sep 15, 2026 | 7,172 | -36.1% | 5,743 | 1.3 |
| Aug 31, 2026 | 11,229 | +2.1% | 14,673 | 1.0 |
| Aug 14, 2026 | 10,999 | -55.2% | 5,965 | 1.8 |
| Jul 31, 2026 | 24,556 | -32.1% | 3,523 | 7.0 |
| Jul 15, 2026 | 36,172 | +286.4% | 57,229 | 1.0 |
| Jun 30, 2026 | 9,362 | -24.0% | 342,910 | 1.0 |
| Jun 15, 2026 | 12,314 | +26.3% | 13,534 | 1.0 |
| May 29, 2026 | 9,750 | -49.3% | 26,934 | 1.0 |
| May 15, 2026 | 19,218 | -97.2% | 239,726 | 1.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?